GLENN LEVINE to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications GLENN LEVINE has written about Platelet Aggregation Inhibitors.
Connection Strength
5.179
-
Balancing Ischemic and Bleeding Risks of Prolonged Dual Antiplatelet Therapy. JAMA. 2017 07 11; 318(2):194-195.
Score: 0.478
-
It Is Time to End the Dualistic Short Versus Long Duration of Dual Antiplatelet Therapy Debates. Circulation. 2017 06 20; 135(25):2451-2453.
Score: 0.476
-
Adding CABG to the Dual Antiplatelet?Salad. J Am Coll Cardiol. 2017 01 17; 69(2):128-130.
Score: 0.462
-
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2016 11; 152(5):1243-1275.
Score: 0.455
-
2016 ACC/AHA Guideline Focused?Update on Duration of Dual?Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines. J Am Coll Cardiol. 2016 09 06; 68(10):1082-115.
Score: 0.437
-
Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol. 2014 Oct; 11(10):597-606.
Score: 0.391
-
World heart federation expert consensus statement on antiplatelet therapy in east asian patients with ACS or undergoing PCI. Glob Heart. 2014 Dec; 9(4):457-67.
Score: 0.391
-
Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: a guide for pharmacists and other health care professionals. Pharmacotherapy. 2006 Nov; 26(11):1537-56.
Score: 0.228
-
Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association. Circulation. 2022 10 11; 146(15):e205-e223.
Score: 0.171
-
Meta-Analysis of Brief Dual-Antiplatelet Therapy Duration After Percutaneous Coronary Intervention. Am J Cardiol. 2022 07 01; 174:182-184.
Score: 0.167
-
Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review. JAMA. 2021 Apr 20; 325(15):1545-1555.
Score: 0.155
-
Antithrombotic therapy in patients with acute coronary syndromes. Arch Intern Med. 2001 Apr 09; 161(7):937-48.
Score: 0.155
-
Reduction of thrombus burden with eptifibatide in a patient with a non-ST segment elevation acute coronary syndrome. J Invasive Cardiol. 2000 Dec; 12 Suppl D:21D-2D.
Score: 0.151
-
A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery Disease. Can J Cardiol. 2020 08; 36(8):1298-1307.
Score: 0.141
-
Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis. BMJ. 2019 Oct 10; 367:l5476.
Score: 0.140
-
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction? J Cardiovasc Pharmacol Ther. 2019 05; 24(3):215-224.
Score: 0.132
-
ACC/AHA Versus ESC Guidelines on Dual?Antiplatelet Therapy: JACC Guideline Comparison. J Am Coll Cardiol. 2018 12 11; 72(23 Pt A):2915-2931.
Score: 0.132
-
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018 01 14; 39(3):213-260.
Score: 0.124
-
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2018 01 01; 53(1):34-78.
Score: 0.123
-
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation. 2016 Sep 06; 134(10):e123-55.
Score: 0.109
-
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2012 Feb 15; 79(3):453-95.
Score: 0.082
-
In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin. Am J Cardiol. 2002 Jan 01; 89(1):61-4.
Score: 0.041
-
Is There an Optimal Antiplatelet Strategy after Gastrointestinal Bleeding in Patients with Coronary Artery Disease? Cardiology. 2021; 146(6):668-677.
Score: 0.040